Jean-Paul Sculier (Brussels, Belgium), Fernando Gamarra (Straubing, Germany)
LATE-BREAKING ABSTRACT: Overall survival after the introduction of CT-based follow-up after resection of lung cancer. A population based quality assurance analysis
Niels-Christian Gerner Hansen (Odense C, Denmark), Niels-Chr. G. Hansen, Stefan Starup Jeppesen, Erik Jakobsen
|   |
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial
Shirish Gadgeel (Detroit, United States of America), Shirish Gadgeel, Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassileios Georgoulias, Wei Li, Dolores Isla, Salih Zeki Guclu, Alessandro Morabito, Young Joo Min, Andreas Ardizzoni, Bushi Wang, Vikram Chand, Glenwood Goss, For the LUX-Lung 8 Investigators
|  |
Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer
Anca Franzini (St Gallen, Switzerland), Anca Franzini, Florent Baty, Martin Brutsche
| |
Clinical characteristics of 32 patients with BRAF V600E-mutated lung adenocarcinoma
Audrey Benguigui (Rouen, France), Audrey Benguigui, Florian Guisier, Aude Lamy, Suzanna Bota, Samy Lachkar, Mathieu Salaün, Luc Thiberville
| |
Cox-2 inhibitors in the treatment of small cell lung cancer patients
Efimia Boutsikou (Thessaloniki, Greece), Efimia Boutsikou, Paul Zarogoulidis, Tania Konstanta, Sofia Lampaki, Lefteris Vlogiaris, Dionisis Spyratos, Konstantinos Zarogoulidis
| |
Does smoking status after a diagnosis of lung cancer matter? Impact of quitting on 1 year survival
Rachel Roberts (llanelli, United Kingdom), Rachel Roberts, Keir Lewis
| |
A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP study
Thierry Berghmans (Brussels, Belgium), Thierry Berghmans, Jean-Jacques Lafitte, Marianne Paesmans, Anne-Pascale Meert, Arnaud Scherpereel, Oswald Van Cutsem, Benoit Colinet, Paul Van Houtte, Martine Roelandts, Nathalie Leclercq, Jean-Paul Sculier
| |
Consolidation maintenance oral vinorelbine following concurrent chemoradiation of intravenous vinorelbine and cisplatin in patients with unresectable stage III non-small cell lung cancer
Yaser Ahmad (Assuit, Egypt), Yaser Elkelhy, Samer Eid, M.M. Omar, Tarek Salah
| |